The Journal of Pediatrics
Volume 158, Issue 1 , Pages 44-50 , January 2011

The Triglyceride to High-Density Lipoprotein–Cholesterol Ratio in Adolescence and Subsequent Weight Gain Predict Nuclear Magnetic Resonance–Measured Lipoprotein Subclasses in Adulthood

  • Ram Weiss, MD, PhD

      Affiliations

    • Braun School of Public Health and Community Medicine, Hebrew University-Hadassah Faculty of Medicine, Jerusalem, Israel
    • Corresponding Author InformationReprint requests: Ram Weiss, MD, PhD, Department of Human Nutrition and Metabolism, Braun School of Public Health, PO Box 12272, Ein Kerem 91120, Hebrew University School of Medicine, Jerusalem.
    • ,
  • James D. Otvos, PhD

      Affiliations

    • LipoScience Inc, Raleigh, NC
    • ,
  • Ronit Sinnreich, PhD

      Affiliations

    • Braun School of Public Health and Community Medicine, Hebrew University-Hadassah Faculty of Medicine, Jerusalem, Israel
    • ,
  • Andre R. Miserez, MD

      Affiliations

    • Research Laboratories, Diagene Inc., Reinach Switzerland and University of Basel, Switzerland
    • ,
  • Jeremy D. Kark, MD, PhD

      Affiliations

    • Braun School of Public Health and Community Medicine, Hebrew University-Hadassah Faculty of Medicine, Jerusalem, Israel

Received 22 November 2009 ,Revised 27 April 2010 ,Accepted 7 July 2010.

References 

  1. Wattigney WA, Webber LS, Srinivasan SR, Berenson GS. The emergence of clinically abnormal levels of cardiovascular disease risk factor variables among young adults: the Bogalusa Heart Study. Prev Med. 1995;24:617–626
  2. Bao W, Srinivasan SR, Wattigney WA, Berenson GS. Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood. The Bogalusa Heart Study. Arch Intern Med. 1994;154:1842–1847
  3. Webber LS, Srinivasan SR, Wattigney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. Am J Epidemiol. 1991;133:884–899
  4. Porkka KV, Viikari JS, Taimela S, Dahl M, Akerblom HK. Tracking and predictiveness of serum lipid and lipoprotein measurements in childhood: a 12-year follow-up. The Cardiovascular Risk in Young Finns study. Am J Epidemiol. 1994;140:1096–1110
  5. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362–2374
  6. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494–2497
  7. Adiels M, Olofsson SO, Taskinen MR, Boren J. Diabetic dyslipidaemia. Curr Opin Lipidol. 2006;17:238–246
  8. Cordero A, Andrés E, Ordoñez B, León M, Laclaustra M, Grima A, et al. Usefulness of triglycerides-to-high-density lipoprotein cholesterol ratio for predicting the first coronary event in men. Metabolic Syndrome Active Subjects Study Investigators. Am J Cardiol. 2009;104:1393–1397
  9. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest. 1993;92:141–146
  10. Krauss RM. Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler Thromb Vasc Biol. 2005;25:2265–2272
  11. Lamarche B, Tchernof A, Mauriège P, Cantin B, Dagenais GR, Lupien PJ, et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA. 1998;279:1955–1961
  12. Chan DT, Irish AB, Dogra GK, Watts GF. Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials. Atherosclerosis. 2008;196:823–834
  13. Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr. 2003;22:331–339
  14. Slater PE, Friedlander Y, Baras M, Harlap S, Halfon ST, Kaufmann NA, et al. The Jerusalem Lipid Research Clinic: sampling, response and selected methodological issues. Isr J Med Sci. 1982;18:1106–1112
  15. Kark JD, Sinnreich R, Leitersdorf E, Friedlander Y, Shpitzen S, Luc G. Taq 1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol. Atherosclerosis. 2000;151:509–518
  16. Otvos J. Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopy. Clin Cardiol. 1999;22(Suppl):II21–II27
  17. Otovs JD. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. In:  Rifai N,  Wainick R,  Cominazak M editor. Handbook of lipoprotein testing. Washington: AACC Press; 2000;p. 609–623
  18. Jeyarajah EJ, Cromwell WC, Otvos JD. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med. 2006;26:847–870
  19. Festa A, Williams K, Hanley AJ, Otvos JD, Goff DC, Wagenknecht LE, et al. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study. Circulation. 2005;111:3465–3472
  20. Tirosh A, Rudich A, Shochat T, Tekes-Manova D, Israeli E, Henkin Y, et al. Changes in triglyceride levels and risk for coronary heart disease in young men. Ann Intern Med. 2007;147:377–385
  21. Tirosh A, Shai I, Bitzur R, Kochba I, Tekes-Manova D, Israeli E, et al. Changes in triglyceride levels over time and risk of type 2 diabetes in young men. Diabetes Care. 2008;31:2032–2037
  22. Kwiterovich PO. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity. Am J Cardiol. 2002;90(8A):30i-347
  23. Barbagallo CM, Fan J, Blanche PJ, Rizzo M, Taylor JM, Krauss RM. Overexpression of human hepatic lipase and ApoE in transgenic rabbits attenuates response to dietary cholesterol and alters lipoprotein subclass distributions. Arterioscler Thromb Vasc Biol. 1999;19:625–632
  24. Klos KL, Kardia SL, Ferrell RE, Turner ST, Boerwinkle E, Sing CF. Genome-wide linkage analysis reveals evidence of multiple regions that influence variation in plasma lipid and apolipoprotein levels associated with risk of coronary heart disease. Arterioscler Thromb Vasc Biol. 2001;21:971–978
  25. Friedlander Y, Kark JD, Sinnreich R, Edwards KL, Austin MA. Inheritance of LDL peak particle diameter: results from a segregation analysis in Israeli families. Genet Epidemiol. 1999;16:382–396
  26. Howard BV, Ruotolo G, Robbins DC. Obesity and dyslipidemia. Endocrinol Metab Clin North Am. 2003;32:855–867
  27. Cali AM, Zern TL, Taksali SE, de Oliveira AM, Dufour S, Otvos JD, et al. Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect proatherogenic state. Diabetes Care. 2007;30:3093–3098
  28. Baker JL, Olsen LW, Sørensen TI. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med. 2007;357:2329–2337
  29. Pascot A, Lemieux I, Prud'homme D, Tremblay A, Nadeau A, Couillard C, et al. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res. 2001;42:2007–2014

 Supported by the US-Israel Binational Science Foundation, the Israel Science Foundation, and the Stephen Morse Diabetes Research Fund. J.D.O. is employed by, is a stockholder of, and serves on the board of directors of LipoScience, a diagnostic laboratory company that performed the lipoprotein subclass analyses described in the manuscript. The remaining authors declare no conflicts of interest

PII: S0022-3476(10)00580-9

doi: 10.1016/j.jpeds.2010.07.002

The Journal of Pediatrics
Volume 158, Issue 1 , Pages 44-50 , January 2011

Article Tools

* Image Usage & Resolution